Lindbrook Capital’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-315
Closed -$1K 2889
2022
Q1
$1K Hold
315
﹤0.01% 2449
2021
Q4
$0 Buy
+315
New +$631 ﹤0.01% 2249

Lindbrook Capital's TLMD Position: Q2 2022 in Review

Lindbrook Capital sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 315 shares — an estimated $1K sold.

Lindbrook Capital first reported a position in TLMD in Q4 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2022. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

  • Lindbrook Capital reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Lindbrook Capital sold 315 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $1K.
  • Lindbrook Capital first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2021 and held it in 2 quarters.
  • Lindbrook Capital's SOC Telemed, Inc. Class A Common Stock position peaked at $1K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Lindbrook Capital's 13F filing for Q2 2022, filed 1 Aug 2022.